Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
The 340B Drug Pricing Program was meant to help low-income patients, writes Rick Dowlearn, but it’s being used by hospitals ...
Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York ...
INDIANAPOLIS (Indiana Capital Chronicle) — A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning ...
Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs ...
In politics, there is far too often far too much focus on what’s happening in Washington, D.C. and whatever Beltway politicians and the national media deem to be the “news of the day.” ...
Hospitals are suing to block a Trump administration pilot that will allow drugmakers to issue post-sale rebates instead of upfront discounts on medications in the 340B drug discount program, arguing ...
The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.
This past September, a sub-agency of the Department of Health and Human Services (HHS) threatened to kick a pharmaceutical company out of Medicare because the company, in line with federal law, ...
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results